MANILA, Philippines — The Department of Science and Technology (DOST) and the Philippine Coconut Authority (PCA) need to fund more studies to prove the health benefits of virgin coconut oil (VCO), a coconut processors group said.
The VCO Producers and Traders Association of the Philippines (VCO Philippines) said a 2021 clinical trial on VCO as an effective adjunct treatment for COVID-19 cases in Valenzuela City has gained international publication.
The group said studies on the coconut derivative product would be a big boon to the coconut farming industry as well as the coconut processing industry, showing the multiplier effects of such government assistance to the sector.
VCO Philippines issued the call after a study spearheaded by the DOST-Food Nutrition and Research Institute (DOST-FNRI) titled, “Virgin coconut oil (VCO) supplementation relieves symptoms and inflammation amoing COVID-19 positive adults: A single-blind randomized trial,” was published by the Cambridge University Press on their prestigious Journal of Nutritional Science last Jan. 23.
The Journal of Nutritional Science is an international, peer-reviewed, online only, open access journal that welcomes high-quality research articles in all aspects of nutrition. The journal says that the underlying aim of all published research should be the development of nutritional concepts.
“More studies on the efficacy of VCO should be considered to determine whether VCO can provide safe and affordable adjunct therapy against viruses. This will also be valuable support for the VCO industry,” VCO Philippines said.